Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRL
#862
Charles River Laboratories International, Inc. Common Stock
226.1
4
USD
-0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.92%
Monthly Change
+18.73%
6 month change
+4.38%
Year Change
+14.88%
Previous Close
228.2
3
Open
227.7
6
Low
224.7
6
High
227.7
6
Volume
251
Markets
US Stock Market
Healthcare
Diagnostics & Research
CRL
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
49.12 M
49.21 M
49.22 M
49.23 M
48.17 M
48.17 M
Valuation ratios
Enterprise value
7.17 B
7.29 B
7.03 B
9.79 B
7.51 B
10.81 B
Price to earnings ratio
-250.87
-118.54
-97.34
-69.81
-43.05
-61.51
Price to sales ratio
1.93
1.92
1.85
2.51
1.96
2.79
Price to cash flow ratio
9.99
9.84
9.91
13.65
13
18.57
Price to book ratio
0.55
0.56
0.55
3.18
0.61
0.88
Enterprise value to EBITDA ratio
4.38
3.22
2.38
3.51
3.37
4.32
Profitability ratios
Return on assets %
0
0.01
0.01
-0.04
-0
-0
Return on equity %
0.01
0.02
0.02
-0.09
-0.01
-0.01
Return on invested capital %
3.57
4.22
4.9
-13.88
3.5
3.5
Gross margin %
99.31
99.58
100.04
99.82
99.85
99.85
Operating margin %
7.59
9.7
13.32
-28.51
12.04
12.04
EBITDA margin %
84.67
73.66
68.29
0.86
77.52
77.52
Net margin %
2.59
5.07
5.42
-27.82
-1.49
-1.49
Liquidity ratios
Quick ratio
1.16
1.1
1.1
1.02
1.03
1.03
Current ratio
1.43
1.36
1.37
1.29
1.36
1.36
Inventory turnover
0.02
0.02
-0
0.01
0
0
Asset turnover
0.13
0.14
0.13
0.14
0.13
0.13
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
0
0.3
0
0
Long term debt to total equity ratio
0
0
0
0.67
0
0
Per share metrics
Operating cash flow per share
3.38
4.15
4.33
2.98
0.84
12.29
EBIT per share
14.02
14.8
15.94
-1.41
14.4
43.73
EBITDA per share
16.39
15.42
13.88
0.17
15.77
45.24
Total debt per share
—
—
—
—
—
—
Cash per share
4.51
3.71
4.19
4.31
3.92
3.92
Net current asset value per share
29.62
29.8
31
29.2
30.41
30.41
Tangible book value per share
62.82
68
68.9
63.85
60.07
60.07
Working capital per share
8.95
7.9
8.3
6.59
8.07
8.07
Book value per share
62.82
68
68.9
63.85
60.07
60.07
News
Abbott Q2 Earnings & Revenues Top Estimates, Stock Up in Pre-market
Is Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year?
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report?
ICON Stock and the CRO Trends Shaping Its Next Growth Phase
Medpace Growth Trends Show How CRO Demand Is Shifting in 2026
Medpace Stock Outlook Turns on Backlog Quality and Cancellations
LH or CRL: Which Is the Better Value Stock Right Now?
Is This the Right Time to Hold CRL Stock in Your Portfolio?
ValuEngine Weekly Market Summary And Commentary
Stock Market Week Ahead: Rotating, For Now, Away From The AI Boom
How Is Charles River Laboratories’ Stock Performance Compared to Other Health Care Stocks?
Morgan Stanley sees writing on wall for key drug research stocks